Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Sallans

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2021
Tocopherol controls D1 amino acid oxidation by oxygen radicals in Photosystem IIAditya Kumar, Ankush Prasad, Michaela Sedlářová, et al.
Biochemistry|May 21, 2016
Use of Protein Cross-Linking and Radiolytic Labeling To Elucidate the Structure of PsbO within Higher-Plant Photosystem IIManjula P Mummadisetti, Laurie K Frankel, Henry D Bellamy, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2010
Airway peroxidases catalyze nitration of the {beta}2-agonist salbutamol and decrease its pharmacological activityKrzysztof J Reszka, Larry Sallans, Stephen Macha, et al.
Investigational New Drugs|July 8, 2022
Brain pharmacokinetics and metabolism of the AMP-activated protein kinase selective inhibitor SBI-0206965, an investigational agent for the treatment of glioblastomaJanki M Desai, Aniruddha S Karve, Gary A Gudelsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Use of protein cross-linking and radiolytic footprinting to elucidate PsbP and PsbQ interactions within higher plant Photosystem IIManjula P Mummadisetti, Laurie K Frankel, Henry D Bellamy, et al.
Proteomics|November 27, 2010
Assaying pharmacodynamic endpoints with targeted therapy: flavopiridol and 17AAG induced dephosphorylation of histone H1.5 in acute myeloid leukemiaLiwen Wang, Sean W Harshman, Shujun Liu, et al.
Molecular Cancer Therapeutics|December 19, 2006
Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancerYelena B Wetherill, Janet K Hess-Wilson, Clay E S Comstock, et al.
BMC Pharmacology & Toxicology|December 6, 2018
Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agentsHari Krishna Ananthula, Scott Parker, Erin Touchette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2024
A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade GliomasPankaj B Desai, Aniruddha S Karve, Misam Zawit, et al.
Science Advances|February 11, 2021
Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancerNicole Oatman, Nupur Dasgupta, Priyanka Arora, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2021
Tocopherol controls D1 amino acid oxidation by oxygen radicals in Photosystem IIAditya Kumar, Ankush Prasad, Michaela Sedlářová, et al.
Biochemistry|May 21, 2016
Use of Protein Cross-Linking and Radiolytic Labeling To Elucidate the Structure of PsbO within Higher-Plant Photosystem IIManjula P Mummadisetti, Laurie K Frankel, Henry D Bellamy, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2010
Airway peroxidases catalyze nitration of the {beta}2-agonist salbutamol and decrease its pharmacological activityKrzysztof J Reszka, Larry Sallans, Stephen Macha, et al.
Investigational New Drugs|July 8, 2022
Brain pharmacokinetics and metabolism of the AMP-activated protein kinase selective inhibitor SBI-0206965, an investigational agent for the treatment of glioblastomaJanki M Desai, Aniruddha S Karve, Gary A Gudelsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Use of protein cross-linking and radiolytic footprinting to elucidate PsbP and PsbQ interactions within higher plant Photosystem IIManjula P Mummadisetti, Laurie K Frankel, Henry D Bellamy, et al.
Proteomics|November 27, 2010
Assaying pharmacodynamic endpoints with targeted therapy: flavopiridol and 17AAG induced dephosphorylation of histone H1.5 in acute myeloid leukemiaLiwen Wang, Sean W Harshman, Shujun Liu, et al.
Molecular Cancer Therapeutics|December 19, 2006
Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancerYelena B Wetherill, Janet K Hess-Wilson, Clay E S Comstock, et al.
BMC Pharmacology & Toxicology|December 6, 2018
Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agentsHari Krishna Ananthula, Scott Parker, Erin Touchette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2024
A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade GliomasPankaj B Desai, Aniruddha S Karve, Misam Zawit, et al.
Science Advances|February 11, 2021
Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancerNicole Oatman, Nupur Dasgupta, Priyanka Arora, et al.
Pageof 4